Clinical Trial Update: PK/PD of EA-230 During Endotoxemia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of EA-230 during endotoxemia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endotoxemia
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• EA-230 (EA-230)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Endotoxemia, Systemic Inflammatory Response | Phase 1 | Status: COMPLETED